Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
description: A Correction to this paper has been published: https://doi.org/10.1038/s41467-021-23082-3
creator: Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell, Alejandro Chavez, David D. Ho
source: Epidemiology and Health
publisher: Korean Society of Epidemiology
date: 2021
coverage: Science